Medivir Mergers & Acquisitions

Medivir M&A Summary

Medivir has acquired 4 companies. It has also divested 2 assets.

Medivir’s largest acquisition to date was in 2016, when it acquired TetraLogic Pharmaceuticals - Oncology Programs for $12M. It’s largest disclosed sale occurred in 2016, when it sold Biophausia AB to Karo Healthcare AB for $107M. Medivir has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (75%) and consumer products (25%).

M&A Summary

  • M&A Total Activity6
    • M&A Buy Activity4
    • M&A Sell Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 3

Medivir

Medivir AB

Lunastigen 5, 2nd floor,
Huddinge, 111 48
Sweden,
+46 8 54 68 31 00
www.medivir.com

All (6) Buy (4) Sell (2)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2016-12-29 TetraLogic Pharmaceuticals Corp. - Oncology Programs · Life Science
Malvern, Pennsylvania

TetraLogic Pharmaceuticals Corp. - Oncology Programs includes clinical stage oncology programs MAC Mimetic and HDAC Inhibitor Assets.

12 Divestiture

Medivir

TetraLogic Pharmaceuticals


Try Mergr Free — See This and 220,677+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.